Sort
130,381 grants matching “hiv”
Optimizing HIV Care in Less Developed Countries
$1,118,696Kenneth Alan Freedberg · Massachusetts General Hospital · R01 · FY2006 · AI
TRACKING HIV INFECTION AND ALCOHOL ABUSE CNS COMORBIDITY WITH NEUROIMAGING
$1,118,312Adolf Pfefferbaum · Sri International · U01 · FY2007 · AA
IMPROVEMENT OF INTEGRATED HIV CLINICAL-BASED SERVICES
$1,118,000Michel Joseph Dodard · University Of Miami School Of Medicine · U2G · FY2011 · GH
Lymphocyte Dynamics
$1,117,836William Paul · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Preclinical Evaluation of Novel Ad/MVA and Ad/Protein HIV-1 Vaccines
$1,117,704Dan H. Barouch · Beth Israel Deaconess Medical Center · U19 · FY2015 · AI
Interaction of HIV envelope with cell surface receptors
$1,117,501Anthony S. Fauci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
NIAID Preclinical Development Support - Development of clade C Vaccine
$1,117,336Nancy Lin · Advanced Bioscience Laboratories, Inc. · N01 · FY2014 · AI
Reversing Tissue Fibrosis to Improve Immune Reconstitution in HIV
$1,117,257Timothy W Schacker · University Of Minnesota · U01 · FY2014 · AI
HIV-1 RNase H as a Therapeutic Target
$1,117,190Stuart F. J. Le Grice · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Molecular and Cellular Biology of HIV Encephalopathy
$1,117,170Francisco A Gonzalez-Scarano · University Of Pennsylvania · P01 · FY2007 · NS
Kaiser Washington Vaccine and Treatment Evaluation Unit
$1,117,166Lisa A Jackson · Kaiser Foundation Research Institute · UM1 · FY2021 · AI
Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in Lymphoma
$1,116,963Douglas F Nixon · Feinstein Institute For Medical Research · R01 · FY2024 · CA
Preventive Vaccines for HIV
$1,116,963Genoveffa Franchini · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Understanding the Role of the Host Response in HIVSIV Infection
$1,116,963Genoveffa Franchini · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Myeloid - T cell interactions that sustain SIV reservoirs during effective antire
$1,116,751Steven Grant Deeks · University Of California, San Francisco · U19 · FY2012 · AI
Cohort Studies on HIV/AIDS and Substance Abuse in Miami
$1,116,569Marianna K Baum · Florida International University · U01 · FY2015 · DA
Pediatric AIDS Clinical Trials Group
$1,116,567St. Jude Children'S Research Hospital · U01 · FY2003 · AI
FOA GH11-1136: STRENGTHENING FACILITY BASED HIV T & C SERVICE IN SWAZILAND
$1,116,493Mohammed Mahdi · Elizabeth Glaser Pediatric Aids Fdn · U2G · FY2013 · GH
Development Of Vaccines For Genital Herpes Simplex Infection
$1,116,436Jeffrey Cohen · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
NIDA Clinical Trials Network: Greater New York Node
$1,116,411John P Rotrosen · New York University School Of Medicine · UG1 · FY2015 · DA
Machine learning to distinguish HAND from Alzheimer's disease in HIV over age 60
$1,116,125Victor Valcour · University Of California, San Francisco · R01 · FY2018 · MH
Understanding Viral Suppression for Newly Diagnosed HIV+ Men to Inform Implementation of TasP and U=U
$1,115,927H. Jonathon Rendina · Whitman-Walker Institute, Inc. · R01 · FY2022 · AI
CBA (HIV) PREVENTION SERVICES FOR RACIAL/ETHNIC MINORITY POPULATIONS
$1,115,730Lina Sheth · Asian And Pacific Islander Wellness Ctr · U65 · FY2007 · PS
CBA (HIV) PREVENTION SERVICES FOR RACIAL/ETHNIC MINORITY POPULATIONS
$1,115,730Lina Sheth · Asian And Pacific Islander Wellness Ctr · U65 · FY2006 · PS
GH11-1152Planning, Implementation and Evaluation of Comprehensive HIV Prevention Programs
$1,115,441Gavin Walton · Careworks · U2G · FY2014 · GH